Delivery Order SPE2DB20D1100-SPE2DB24FA4R9

Award Date 2/28/24
Potential Completion Date 2/29/24
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,175.06 firm-fixed-price delivery order is for the supply of Tribenzor 40-10-25 mg tablets, a medication used to treat hypertension. The contract has an ultimate completion date of September 16, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,068.03 firm fixed-price delivery order (SPE2DB22D2206|SPE2DB25FEV53) is for the supply of TRIBENZOR 20-5-12.5 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of December 24, 2024 and was awarded on December 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,526.89, is for the delivery of Tribenzor 40-5-12.5 mg tablets. The award has an ultimate completion date of April 26, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This federal contract award, valued at $1,481.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract is for the supply of Tribenzor 40-10-25 mg tablets, a pharmaceutical product used in the treatment of cardiovascular...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,235.12 firm fixed price contract is for the delivery of Triamterene-HCTZ 37.5-25 mg tablets in 500-count bottles. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,793.28, is for the supply of Telmisartan-Amlodipine 40-5 mg tablets. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,299.60 firm fixed price delivery order is for the supply of Triamterene-HCTZ 37.5-25 mg tablets in 500-count packages. The contract has an ultimate completion date of September 20, 2024 and does not utilize any set-asides. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,668.35 firm fixed-price delivery order is for the supply of TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a cardiovascular medication. The contract has an ultimate completion date of December 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,561,201,996 units of Triamterene-HCTZ 75-50 mg tablets. The fixed-price, firm-fixed-price delivery order has a ceiling value of $2,804.29 and an ultimate completion date of June 12, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,952.91, is for the delivery of Triamterene-HCTZ 37.5-25 mg tablets in 500-count bottles. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FA4R9
    Delivery Order

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $4,298.26 contract is for the delivery of 4,563,803,628 tablets of the medication Tribenzor 40-10-25 mg. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide a range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 5/29/24, 10:12 AM